Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1998-5-22
pubmed:abstractText
To elucidate the role of interleukin (IL)-8, a chemotactic factor for neutrophils, in dialysis-related arthritis (DRA) of patients on long-term hemodialysis, the concentration of IL-8 was measured in the synovial fluids of DRA patients with acute arthralgia and joint swelling, and was compared with those in patients with rheumatoid arthritis (RA) and patients with osteoarthritis (OA). We noted a marked elevation of IL-8 in the joint fluids of patients with DRA and RA as compared with OA. Furthermore, to determine the role of IL-8 in synovitis, we examined the in vivo effect of intra-articular injection of human recombinant IL-8 on leukocyte infiltration into the joint space of rabbits. A single injection of IL-8 to the joints of rabbits induced rapid infiltration of neutrophils into the joint space and synovial tissues, which reached a maximum in four hours. The oral administration of indometacin farnesil (a prodrug that is converted to indomethacin after intestinal absorption) before the injection of IL-8 alleviated the infiltration of neutrophils. When human synovial cells were incubated with tumor necrosis factor (TNF)-alpha, the expression of IL-8 mRNA and IL-8 production in the cultured synovial cells were increased. The TNF-alpha-stimulated expression of IL-8 mRNA and IL-8 production in the cultured synovial cells were markedly inhibited by dexamethasone. In conclusion, IL-8 levels were markedly elevated in the joint fluids of patients with DRA. Interleukin-8 released from synovial cells may be an important factor to induce acute inflammation in DRA. Dexamethasone and indomethacin may be effective for DRA by inhibiting the production and chemotactic actions of IL-8, respectively.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0085-2538
pubmed:author
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1007-13
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:9551411-Adult, pubmed-meshheading:9551411-Aged, pubmed-meshheading:9551411-Animals, pubmed-meshheading:9551411-Anti-Inflammatory Agents, pubmed-meshheading:9551411-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:9551411-Arthritis, Rheumatoid, pubmed-meshheading:9551411-Cells, Cultured, pubmed-meshheading:9551411-Dexamethasone, pubmed-meshheading:9551411-Female, pubmed-meshheading:9551411-Gene Expression, pubmed-meshheading:9551411-Humans, pubmed-meshheading:9551411-Indomethacin, pubmed-meshheading:9551411-Interleukin-1, pubmed-meshheading:9551411-Interleukin-8, pubmed-meshheading:9551411-Kidney Failure, Chronic, pubmed-meshheading:9551411-Leukocytes, pubmed-meshheading:9551411-Male, pubmed-meshheading:9551411-Middle Aged, pubmed-meshheading:9551411-Osteoarthritis, pubmed-meshheading:9551411-RNA, Messenger, pubmed-meshheading:9551411-Rabbits, pubmed-meshheading:9551411-Renal Dialysis, pubmed-meshheading:9551411-Synovial Fluid, pubmed-meshheading:9551411-Synovial Membrane, pubmed-meshheading:9551411-Tumor Necrosis Factor-alpha
pubmed:year
1998
pubmed:articleTitle
Involvement of interleukin-8 in dialysis-related arthritis.
pubmed:affiliation
Nagoya University Daiko Medical Center, Japan.
pubmed:publicationType
Journal Article